Benjamin S. Harris

Benjamin S. Harris

Auto-generated profile, based on publicly available information

Benjamin S. Harris

Division of Reproductive Endocrinology and Infertility, Duke University Medical Center, Durham, NC

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2022 in Fertility and Sterility
Verified
Journal Article
Closed access
BHBenjamin S. Harris
Benjamin S. Harris
AJAnne Marie Jukic
Anne Marie Jukic
TTTracy Truong
Tracy Truong
CNCaroline T. Nagle
Caroline T. Nagle
AEAlaattin Erkanli
Alaattin Erkanli
ASAnne Z. Steiner
Anne Z. Steiner

11 March 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
BPBenjamin J Peipert
Benjamin J Peipert
ECEsther H Chung
Esther H Chung
BHBenjamin S Harris
Benjamin S Harris
TJTarun Jain
Tarun Jain

1 May 2019 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
BHBenjamin S. Harris
Benjamin S. Harris
RHR. Phillips Heine
R. Phillips Heine
JPJinyoung Park
Jinyoung Park
KFKeturah R. Faurot
Keturah R. Faurot
MHMaeve K. Hopkins
Maeve K. Hopkins
JJJ. Eric Jelovsek
J. Eric Jelovsek

27 March 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
BHBenjamin S Harris
Benjamin S Harris
ASAnne Z Steiner
Anne Z Steiner
AJAnne Marie Jukic
Anne Marie Jukic
Context: While age-related changes in menstrual cycle length are well known, it is unclear whether anti-Müllerian (AMH) or other ovarian reserve biomarkers have a direct association with cycle length. Objective: To determine the association between biomarkers of ovarian reserve and menstrual cycle length. Methods: Secondary analysis using data from time to conceive (TTC), a prospective time to pregnancy cohort study. The age-independent association between cycle length and biomarkers of ovarian reserve was analyzed using linear mixed and marginal models. Study participants were TTC-enrolled women aged 30-44 years with no history of infertility who were attempting to conceive for <3 months were enrolled. Serum AMH, follicle-stimulating hormone, and inhibin B levels were measured on cycle day 2, 3, or 4. Participants recorded daily menstrual cycle data for ≤4 months. The primary outcome was menstrual cycle length; follicular and luteal phase lengths were secondary outcomes. Results: Multivariable analysis included 1880 cycles from 632 women. Compared with AMH levels of 1.6 to 3.4 ng/mL, women with AMH 8 ng/mL had cycles that were 2.15 days longer (95% CI 1.46, 2.83), follicular phases that were 2 days longer (95% CI 0.77, 3.24), and luteal phases that were 1.80 days longer (95% CI 0.71, 2.88). Conclusion: Increasing AMH levels are associated with longer menstrual cycles due to both a lengthening of the follicular and the luteal phase independent of age.

30 September 2024 in Fertility and Sterility
Verified
Journal Article
Closed access
BHBenjamin S. Harris
Benjamin S. Harris
KAKelly S. Acharya
Kelly S. Acharya
SUShakthi Unnithan
Shakthi Unnithan
SNShelby A. Neal
Shelby A. Neal
SMSloane Mebane
Sloane Mebane
SMSuheil J. Muasher
Suheil J. Muasher

9 April 2019 in American Journal of Perinatology Reports
Verified
Journal Article
Open access
PDF file
BHBenjamin S. Harris
Benjamin S. Harris
MHMaeve K. Hopkins
Maeve K. Hopkins
MVMargaret S. Villers
Margaret S. Villers
JWJeremy M. Weber
Jeremy M. Weber
CPCarl Pieper
Carl Pieper
RHR Phillips Heine
R Phillips Heine
Objective To examine the association between perioperative Beta (β))-lactam versus non-β-lactam antibiotics and cesarean delivery surgical site infection (SSI). Study Design Retrospective cohort of women undergoing cesarean delivery from January 1 to December 31, 2014. All women undergoing cesarean after 34 weeks with a postpartum visit were included. Prevalence of SSI was compared between women receiving β-lactam versus non-β-lactam antibiotics. Bivariate analyses were performed using Pearson's Chi-square, Fisher's exact, or Wilcoxon's rank-sum tests. Logistic regression models were fit controlling for possible confounders. Results Of the 929 women included, 826 (89%) received β-lactam prophylaxis and 103 (11%) received a non-β-lactam. Among the 893 women who reported a non-type I (low risk) allergy, 819 (92%) received β-lactam prophylaxis. SSI occurred in 7% of women who received β-lactam antibiotics versus 15% of women who received a non-β-lactam (p = 0.004). β-Lactam prophylaxis was associated with lower odds of SSI compared with non-β-lactam antibiotics (odds ratio [OR] = 0.43; 95% confidence interval [CI] = 0.22–0.83; p = 0.01) after controlling for chorioamnionitis in labor, postlabor cesarean, endometritis, tobacco use, and body mass index (BMI). Conclusion β-Lactam perioperative prophylaxis is associated with lower odds of a cesarean delivery surgical site infection compared with non-β-lactam antibiotics.